BISGIN, A. Et Al. 2012. Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer. BMC CANCER , vol.12 .

BISGIN, A., KARGI, A., YALCIN, A. D., AYDIN, C., EKINCI, D., SAVAS, B., ... ŞANLIOĞLU, S.(2012). Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer. BMC CANCER , vol.12.

BISGIN, Atil Et Al. "Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer," BMC CANCER , vol.12, 2012

BISGIN, Atil Et Al. "Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer." BMC CANCER , vol.12, 2012

BISGIN, A. Et Al. (2012) . "Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer." BMC CANCER , vol.12.

@article{article, author={Atil BISGIN Et Al. }, title={Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer}, journal={BMC CANCER}, year=2012}